TeraPore uses Cornell research to address virus filtration challenges
TeraPore Technologies, co-founded by Rachel Dorin, Ph.D. ’13, and its novel nanofiltration products are changing how the pharmaceutical industry is reducing risk of harmful virus contamination in biological drugs. Read more